期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: HIV is a risk factor for the development of chronic kidney disease. People with chronic kidney disease in the state sector are likely to b......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: HIV and AIDS continues to impose substantial healthcare challenges in sub-Saharan Africa, but there are limited local data comparing inpat......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: Index contact testing is an HIV case-finding approach that elicits sexual or needle-sharing partners, as well as biological children, of p......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: Men who have sex with men (MSM) and transgender (TG) people face human rights violations (HRVs) which impact their access to critical inte......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: High-risk human papillomavirus (HR-HPV) is the primary cause of cervical cancer, leading to over 311 000 global deaths, mainly in low- and......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: The neuropsychiatric side effects of efavirenz occur mainly early during treatment and are usually mild. A lesser-known and serious compli......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: Errors in antiretroviral therapy (ART) use are common in children living with HIV (CLHIV), but there is limited evidence from rural primar......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: Non-communicable diseases (NCDs) are an emerging global public health problem.Objectives: To assess the prevalence of NCDs and their risk ......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
Background: Protease inhibitors (PIs) have been recommended as World Health Organization second -line antiretroviral therapy (ART) for low- to middle ......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
We report a case of dolutegravir resistance in KwaZulu-Natal in a 13-year-old male two years after starting dolutegravir. Resistance most likely devel......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
The number of products that can provide pre-exposure prophylaxis (PrEP) for HIV prevention is expanding, with three now approved in South Africa (oral......
期刊： SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2023; 24 (1)
South Africa has a large burden of bacterial sexually transmitted infections (STIs) with high rates among men who have sex with men (MSM). Randomised ......
